Stelara 90 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FG62D
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,250
Award facts
- Contract value 100% obligated
- $16,249.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $16,249.95 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Stelara 90 mg/mL syringes, with an ultimate completion date of September 29, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order falls under the company's existing Indefinite Delivery Contract with DLA valued at $499,999,999 through November 2026, which authorizes the agency to issue firm fixed-price orders for pharmaceutical products supporting military health facilities worldwide.
Stelara is a biologic immunosuppressant medication commonly used to treat autoimmune conditions such as psoriasis, psoriatic arthritis, and inflammatory bowel disease. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently delivering branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare sites. The company's robust portfolio of federal contract awards demonstrates its capability to provide specialized pharmaceutical products, including other complex medications such as Tecentriq and Xtandi, positioning it as a reliable vendor for military medical supply requirements.
Quick answers
Who was awarded contract SPE2DB25FG62D?
SPE2DB25FG62D was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 8, 2025.
How much is contract SPE2DB25FG62D worth?
The government has obligated $16,250 on SPE2DB25FG62D.
Is contract SPE2DB25FG62D an order under another contract?
Yes. SPE2DB25FG62D is a delivery order under SPE2DB20D9157, an indefinite delivery contract.
Was contract SPE2DB25FG62D competed?
The extent of competition for SPE2DB25FG62D was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award